日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Off-the-shelf third-party HSC-engineered iNKT cells for ameliorating GvHD while preserving GvL effect in the treatment of blood cancers

现成的第三方HSC工程化iNKT细胞,用于在治疗血液癌症时减轻GvHD并保留GvL效应

Yan-Ruide Li ,Samuel Zeng ,Zachary Spencer Dunn ,Yang Zhou ,Zhe Li ,Jiaji Yu ,Yu-Chen Wang ,Josh Ku ,Noah Cook ,Adam Kramer ,Lili Yang

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

开发用于现成癌症免疫疗法的同种异体造血干细胞工程化iNKT细胞

Yan-Ruide Li,Yang Zhou,Yu Jeong Kim,Yanni Zhu,Feiyang Ma,Jiaji Yu,Yu-Chen Wang,Xianhui Chen,Zhe Li,Samuel Zeng,Xi Wang,Derek Lee,Josh Ku,Tasha Tsao,Christian Hardoy,Jie Huang,Donghui Cheng,Amélie Montel-Hagen,Christopher S Seet,Gay M Crooks,Sarah M Larson,Joshua P Sasine,Xiaoyan Wang,Matteo Pellegrini,Antoni Ribas,Donald B Kohn,Owen Witte,Pin Wang,Lili Yang

Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

利用造血干细胞工程改造的不变自然杀伤T细胞疗法治疗癌症

Yanni Zhu,Drake J Smith,Yang Zhou,Yan-Ruide Li,Jiaji Yu,Derek Lee,Yu-Chen Wang,Stefano Di Biase,Xi Wang,Christian Hardoy,Josh Ku,Tasha Tsao,Levina J Lin,Alexander T Pham,Heesung Moon,Jami McLaughlin,Donghui Cheng,Roger P Hollis,Beatriz Campo-Fernandez,Fabrizia Urbinati,Liu Wei,Larry Pang,Valerie Rezek,Beata Berent-Maoz,Mignonette H Macabali,David Gjertson,Xiaoyan Wang,Zoran Galic,Scott G Kitchen,Dong Sung An,Siwen Hu-Lieskovan,Paula J Kaplan-Lefko,Satiro N De Oliveira,Christopher S Seet,Sarah M Larson,Stephen J Forman,James R Heath,Jerome A Zack,Gay M Crooks,Caius G Radu,Antoni Ribas,Donald B Kohn,Owen N Witte,Lili Yang